THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME
Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland) in comparison with the original valsartan Diovan® (Novartis, Switzerland) in patients with arterial hypertension (HT) of 1-2 degrees and metabolic syndrome. Material and Methods. 30 hypertensive patients (12 men...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/394 |
| _version_ | 1797232439693672448 |
|---|---|
| author | S. Yu. Martsevich Yu. V. Lukina N. A. Dmitrieva O. V. Lerman S. N. Tolpygina V. P. Voronina L. Yu. Drozdova |
| author_facet | S. Yu. Martsevich Yu. V. Lukina N. A. Dmitrieva O. V. Lerman S. N. Tolpygina V. P. Voronina L. Yu. Drozdova |
| author_sort | S. Yu. Martsevich |
| collection | DOAJ |
| description | Aim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland) in comparison with the original valsartan Diovan® (Novartis, Switzerland) in patients with arterial hypertension (HT) of 1-2 degrees and metabolic syndrome. Material and Methods. 30 hypertensive patients (12 men and 18 women) were enrolled in a randomized open-label crossover study. Each patient received generic and original valsartan (80 mg QD) sequentially during 8 weeks. When target blood pressure (BP) level (<130/80 mm Hg) was not reached, a fixed combination of valsartan with hydrochlorothiazide (80/12.5 mg, and then 160/12.5 mg), and bisoprolol 5 mg/daily , if necessary , were used. Treatment efficacy and safety was assessed at visit to doctor every 2 weeks throughout the study. The sequence of drug use was determined by randomization. Results. Systolic BP (SBP) decreased by 27.5 and 27.4 mm Hg from baseline due to generic and original valsartan 8 week treatment, respectively. Diastolic BP (DBP) decreased by 12.8 and 12.9 mm Hg , respectively (p>0.05). Target BP was achieved in 23 patients (77%) in both randomized groups. Serious adverse reaction were not observed during the treatment with both valsartan drugs. Conclusion. The therapeutic equivalence of generic and original valsartan drugs is shown. Therapy based on valsartan (in combination) was safe and effective in 77% of patients with HT of 1-2 degrees and metabolic syndrome. |
| first_indexed | 2024-03-08T14:05:46Z |
| format | Article |
| id | doaj.art-344bc06f684547f0b126788ea9b90c17 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T16:00:18Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-344bc06f684547f0b126788ea9b90c172024-04-01T07:43:25ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0181172210.20996/1819-6446-2012-8-1-17-22394THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROMES. Yu. Martsevich0Yu. V. Lukina1N. A. Dmitrieva2O. V. Lerman3S. N. Tolpygina4V. P. Voronina5L. Yu. Drozdova6State Research Center for Preventive Medicine I.M. Setchenov First Moscow State Medical UniversityState Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineAim. To study the efficacy and safety of generic valsartan Valz (Actavis Group, Iceland) in comparison with the original valsartan Diovan® (Novartis, Switzerland) in patients with arterial hypertension (HT) of 1-2 degrees and metabolic syndrome. Material and Methods. 30 hypertensive patients (12 men and 18 women) were enrolled in a randomized open-label crossover study. Each patient received generic and original valsartan (80 mg QD) sequentially during 8 weeks. When target blood pressure (BP) level (<130/80 mm Hg) was not reached, a fixed combination of valsartan with hydrochlorothiazide (80/12.5 mg, and then 160/12.5 mg), and bisoprolol 5 mg/daily , if necessary , were used. Treatment efficacy and safety was assessed at visit to doctor every 2 weeks throughout the study. The sequence of drug use was determined by randomization. Results. Systolic BP (SBP) decreased by 27.5 and 27.4 mm Hg from baseline due to generic and original valsartan 8 week treatment, respectively. Diastolic BP (DBP) decreased by 12.8 and 12.9 mm Hg , respectively (p>0.05). Target BP was achieved in 23 patients (77%) in both randomized groups. Serious adverse reaction were not observed during the treatment with both valsartan drugs. Conclusion. The therapeutic equivalence of generic and original valsartan drugs is shown. Therapy based on valsartan (in combination) was safe and effective in 77% of patients with HT of 1-2 degrees and metabolic syndrome.https://www.rpcardio.online/jour/article/view/394valsartanarterial hypertensionmetabolic syndromecombined antihypertensive therapyfixed combinations |
| spellingShingle | S. Yu. Martsevich Yu. V. Lukina N. A. Dmitrieva O. V. Lerman S. N. Tolpygina V. P. Voronina L. Yu. Drozdova THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME Рациональная фармакотерапия в кардиологии valsartan arterial hypertension metabolic syndrome combined antihypertensive therapy fixed combinations |
| title | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME |
| title_full | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME |
| title_fullStr | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME |
| title_full_unstemmed | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME |
| title_short | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME |
| title_sort | comparative study of efficacy and tolerability of generic and original valsartan as a monotherapy or in combination with hydrochlorothiazide and bisoprolol in patients with arterial hypertension of 1 2 degree and metabolic syndrome |
| topic | valsartan arterial hypertension metabolic syndrome combined antihypertensive therapy fixed combinations |
| url | https://www.rpcardio.online/jour/article/view/394 |
| work_keys_str_mv | AT syumartsevich thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT yuvlukina thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT nadmitrieva thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT ovlerman thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT sntolpygina thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT vpvoronina thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT lyudrozdova thecomparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT syumartsevich comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT yuvlukina comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT nadmitrieva comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT ovlerman comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT sntolpygina comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT vpvoronina comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome AT lyudrozdova comparativestudyofefficacyandtolerabilityofgenericandoriginalvalsartanasamonotherapyorincombinationwithhydrochlorothiazideandbisoprololinpatientswitharterialhypertensionof12degreeandmetabolicsyndrome |